1. Butt, Y, Kurdowska, A, Allen, TC. Acute lung injury: A clinical and molecular review. Arch Pathol Lab Med 2016; 140: 345–350.
Google Scholar | Crossref | Medline2. Kuldanek, SA, Kelher, M, Silliman, CC. Risk factors, management and prevention of transfusion-related acute lung injury: A comprehensive update. Expert Rev Hematol 2019; 12: 773–785.
Google Scholar | Crossref | Medline3. Schmidt, GA. Managing acute lung injury. Clin Chest Med 2016; 37: 647–658.
Google Scholar | Crossref | Medline4. Hughes, KT, Beasley, MB. Pulmonary manifestations of acute lung injury: More than just diffuse alveolar damage. Arch Pathol Lab Med 2017; 141: 916–922.
Google Scholar | Crossref | Medline5. Patel, VJ, Biswas Roy, S, Mehta, HJ, et al. Alternative and natural therapies for acute lung injury and acute respiratory distress syndrome. Biomed Res Int 2018; 2018: 2476824.
Google Scholar | Crossref | Medline6. Rajasekaran, S, Pattarayan, D, Rajaguru, P, et al. MicroRNA regulation of acute lung injury and acute respiratory distress syndrome. J Cell Physiol 2016; 231: 2097–2106.
Google Scholar | Crossref | Medline7. Zhao, Z, Hao, J, Li, X, et al. miR-21-5p regulates mycobacterial survival and inflammatory responses by targeting Bcl-2 and TLR4 in Mycobacterium tuberculosis-infected macrophages. FEBS Lett 2019; 593: 1326–1335.
Google Scholar | Crossref | Medline8. Ma, Y, Liu, Y, Hou, H, et al. miR-150 predicts survival in patients with sepsis and inhibits LPS-induced inflammatory factors and apoptosis by targeting NF-κB1 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2018; 500: 828–837.
Google Scholar | Crossref | Medline9. Zhu, S, Song, W, Sun, Y, et al. miR-342 attenuates lipopolysaccharide-induced acute lung injury via inhibiting MAPK1 expression. Clin Exp Pharmacol Physiol 2020; 47: 1448–1454.
Google Scholar | Crossref | Medline10. Li, P, Yao, Y, Ma, Y, et al. miR-150 attenuates LPS-induced acute lung injury via targeting AKT3. Int Immunopharmacol 2019; 75: 105794.
Google Scholar | Crossref | Medline11. Wang, H, Wang, C, Tian, W, et al. The crucial role of SRPK1 in IGF-1-induced EMT of human gastric cancer. Oncotarget 2017; 8: 72157–72166.
Google Scholar | Crossref | Medline12. Van den Bossche, J, Saraber, DL. Metabolic regulation of macrophages in tissues. Cell Immunol 2018; 330: 54–59.
Google Scholar | Crossref | Medline13. Reyes-Gordillo, K, Shah, R, Arellanes-Robledo, J, et al. Akt1 and Akt2 isoforms play distinct roles in regulating the development of inflammation and fibrosis associated with alcoholic liver disease. Cells 2019; 8: 1337.
Google Scholar | Crossref14. Ding, L, Zhang, L, Kim, M, et al. Akt3 kinase suppresses pinocytosis of low-density lipoprotein by macrophages via a novel WNK/SGK1/Cdc42 protein pathway. J Biol Chem 2017; 292: 9283–9293.
Google Scholar | Crossref | Medline15. Gu, S, Dai, H, Zhao, X, et al. AKT3 deficiency in M2 macrophages impairs cutaneous wound healing by disrupting tissue remodeling. Aging (Albany NY) 2020; 12: 6928–6946.
Google Scholar | Crossref | Medline16. Juwen, C, DuBois, AK, Ray, RC, et al. Akt3-mediated protection against inflammatory demyelinating disease. Front Immunol 2019; 10: 1738.
Google Scholar | Crossref | Medline17. Manley, JL, Krainer, AR. A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). Genes Dev 2010; 24: 1073–1074.
Google Scholar | Crossref | Medline | ISI18. Zhou, Z, Fu, XD. Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma 2013; 122: 191–207.
Google Scholar | Crossref | Medline19. Aubol, BE, Plocinik, RM, Hagopian, JC, et al. Partitioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases. J Mol Biol 2013; 425: 2894–2909.
Google Scholar | Crossref | Medline20. Ren, G, Sheng, L, Liu, H, et al. The crucial role of SRPK1 in TGF-β-induced proliferation and apoptosis in the esophageal squamous cell carcinomas. Med Oncol 2015; 32: 209.
Google Scholar | Crossref | Medline21. Wang, P, Zhou, Z, Hu, A, et al. Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt. Mol Cell 2014; 54: 378–391.
Google Scholar | Crossref | Medline22. Li, ZR, Jiang, Y, Hu, JZ, et al. SOX2 knockdown inhibits the migration and invasion of basal cell carcinoma cells by targeting the SRPK1-mediated PI3K/AKT signaling pathway. Oncol Lett 2019; 17: 1617–1625.
Google Scholar | Medline23. Li, XG, Wang, YB. SRPK1 gene silencing promotes vascular smooth muscle cell proliferation and vascular remodeling via inhibition of the PI3K/Akt signaling pathway in a rat model of intracranial aneurysms. CNS Neurosci Ther 2019; 25: 233–244.
Google Scholar | Crossref | Medline